| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.24 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.21 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |